エフィエント錠３．７５ｍｇ
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB06209 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 100 |
| 日本商品名（例） | エフィエント錠２．５ｍｇ, エフィエント錠３．７５ｍｇ, エフィエント錠５ｍｇ |
承認適応症（KEGG）
狭心症、心筋梗塞
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | pulmonary hypertension | 99% | DL |
| 2 | migraine disorder | 99% | DL |
| 3 | migraine with brainstem aura | 99% | DL |
| 4 | kyphoscoliotic heart disease | 99% | DL |
| 5 | rheumatoid arthritis | 99% | DL |
| 6 | homozygous familial hypercholesterolemia | 99% | DL |
| 7 | hypoalphalipoproteinemia | 99% | DL |
| 8 | migraine with or without aura, susceptibility to | 99% | DL |
| 9 | brachydactyly-syndactyly syndrome | 99% | DL |
| 10 | leprosy | 99% | DL |
| 11 | obsolete susceptibility to ischemic stroke | 99% | DL |
| 12 | atrophoderma vermiculata | 99% | DL |
| 13 | peripheral vascular disease | 99% | DL |
| 14 | hypertrichosis (disease) | 99% | DL |
| 15 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | 99% | DL |
| 16 | pulmonary hypertension, primary, autosomal recessive | 99% | DL |
| 17 | Prinzmetal angina | 99% | DL |
| 18 | peripheral arterial disease | 99% | DL |
| 19 | obsolete familial combined hyperlipidemia | 99% | DL |
| 20 | ulerythema ophryogenesis | 99% | DL |
| 21 | obsolete patella aplasia, coxa vara, and tarsal synostosis | 99% | DL |
| 22 | Ambras type hypertrichosis universalis congenita | 99% | DL |
| 23 | myelodysplastic syndrome | 99% | DL |
| 24 | gout | 99% | DL |
| 25 | tendinitis | 99% | DL |
| 26 | intermittent vascular claudication | 99% | DL |
| 27 | fibromyalgia | 99% | DL |
| 28 | malformation syndrome with odontal and/or periodontal component | 99% | DL |
| 29 | syndrome with a Dandy-Walker malformation as major feature | 99% | DL |
| 30 | headache disorder | 99% | DL |
| 31 | coxopodopatellar syndrome | 99% | DL |
| 32 | idiopathic granulomatous myositis | 99% | DL |
| 33 | myositis fibrosa | 99% | DL |
| 34 | unclassified myelodysplastic syndrome | 99% | DL |
| 35 | familial clubfoot due to 17q23.1q23.2 microduplication | 99% | DL |
| 36 | chromosome 17q23.1-q23.2 deletion syndrome | 99% | DL |
| 37 | partial deletion of the long arm of chromosome 5 | 99% | DL |
| 38 | refractory cytopenia of childhood | 99% | DL |
| 39 | aregenerative anemia | 99% | DL |
| 40 | isolated genetic hair shaft abnormality | 99% | DL |
| 41 | female breast carcinoma | 99% | DL |
| 42 | idiopathic pulmonary arterial hypertension | 99% | DL |
| 43 | idiopathic and/or familial pulmonary arterial hypertension | 99% | DL |
| 44 | severe congenital hypochromic anemia with ringed sideroblasts | 99% | DL |
| 45 | cor pulmonale | 99% | DL |
| 46 | nephrogenic syndrome of inappropriate antidiuresis | 98% | DL |
| 47 | heritable pulmonary arterial hypertension | 98% | DL |
| 48 | trigeminal autonomic cephalalgia | 98% | DL |
| 49 | intracranial arteriosclerosis | 98% | DL |
| 50 | pulmonary hypertension, primary | 98% | DL |
（上位50件を表示。全100件の予測があります）
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。